Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 279

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study

Open access
Deftereos, Spyridon, Giannopoulos, Georgios, Angelidis, Christos, Alexopoulos, Nikolaos, Filippatos, Gerasimos, Papoutsidakis, Nikolaos, Sianos, George, Goudevenos, John, Alexopoulos, Dimitrios, Pyrgakis, Vlasios, Cleman, Michael W., Manolis, Antonis S., Tousoulis, Dimitrios, Lekakis, John · 2015 · Circulation

Abstract

Background—: Inflammatory processes have been identified as key mediators of the deleterious effects of ischemia/reperfusion in ST-segment–elevation myocardial infarction. Colchicine is a substance with potent anti-inflammatory properties, suitable for safe use in patients with cardiovascular disease. The purpose of this study was to test the hypothesis that a short course of colchicine treatment could lead to reduced infarct size. Methods and Results—: Patients presenting with ST-segment–elevation myocardial infarction ≤12 hours from pain onset (treated with primary percutaneous coronary intervention) were randomly assigned to colchicine or placebo for 5 days. The primary outcome parameter was the area under the curve of creatine kinase-myocardial brain fraction concentration. A subset of patients underwent cardiac MRI with late gadolinium enhancement 6 to 9 days after the index ST-segment–elevation myocardial infarction. One hundred fifty-one patients were included (60 in the MRI substudy). The area under the creatine kinase-myocardial brain fraction curve was 3144 (interquartile range [IQR], 1754–6940) ng·h –1 ·mL –1 in the colchicine group in comparison with 6184 (IQR, 4456–6980) ng·h –1 ·mL –1 in controls ( P <0.001). Indexed MRI-late gadolinium enhancement–defined infarct size was 18.3 (IQR, 7.6–29.9) mL/1.73 m 2 in the colchicine group versus 23.2 (18.5–33.4) mL/1.73 m 2 in controls ( P =0.019). The relative infarct size (as a proportion to left ventricular myocardial volume) was 13.0 (IQR, 8.0–25.3) % and 19.8 (IQR, 13.7–29.8) %, respectively ( P =0.034). Conclusions—: These results suggest a potential benefit of colchicine in ST-segment–elevation myocardial infarction, but further clinical trials are necessary to draw secure conclusions, especially considering the fact that the present study was not powered to assess clinical end points. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01936285.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.017611

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 279

Metadata

Authors
Deftereos, S., Giannopoulos, G., Angelidis, C., Alexopoulos, N., Filippatos, G., Papoutsidakis, N., Sianos, G., Goudevenos, J., Alexopoulos, D., Pyrgakis, V., Cleman, M. W., Manolis, A. S., Tousoulis, D., & Lekakis, J.
Venue
Circulation
Published
2015-10-13
Volume
132
Issue
15
Pages
1395-1403
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1893844572
Cited by
279
References
39
FWCI
11.24
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study. https://app.cochat.ai/papers/10.1161/circulationaha.115.017611
The paper
Deftereos, S., Giannopoulos, G., Angelidis, C., Alexopoulos, N., Filippatos, G., Papoutsidakis, N., Sianos, G., Goudevenos, J., Alexopoulos, D., Pyrgakis, V., Cleman, M. W., Manolis, A. S., Tousoulis, D., & Lekakis, J. (2015). Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study. Circulation. https://doi.org/10.1161/circulationaha.115.017611

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.